- Home
- TIXT vs AMPH Comparison
TIXT vs AMPH Comparison
Compare TIXT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIXT
- AMPH
- Stock Information
- Founded
- TIXT 2005
- AMPH 1996
- Country
- TIXT Canada
- AMPH United States
- Employees
- TIXT N/A
- AMPH N/A
- Industry
- TIXT EDP Services
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- TIXT Technology
- AMPH Health Care
- Exchange
- TIXT Nasdaq
- AMPH Nasdaq
- Market Cap
- TIXT 1.0B
- AMPH 1.1B
- IPO Year
- TIXT 2021
- AMPH 2014
- Fundamental
- Price
- TIXT $4.47
- AMPH $29.42
- Analyst Decision
- TIXT Hold
- AMPH Buy
- Analyst Count
- TIXT 6
- AMPH 6
- Target Price
- TIXT $3.90
- AMPH $35.50
- AVG Volume (30 Days)
- TIXT 2.0M
- AMPH 623.4K
- Earning Date
- TIXT 08-01-2025
- AMPH 08-07-2025
- Dividend Yield
- TIXT N/A
- AMPH N/A
- EPS Growth
- TIXT N/A
- AMPH N/A
- EPS
- TIXT N/A
- AMPH 2.68
- Revenue
- TIXT $2,718,000,000.00
- AMPH $722,679,000.00
- Revenue This Year
- TIXT $5.34
- AMPH $1.06
- Revenue Next Year
- TIXT $3.07
- AMPH $7.06
- P/E Ratio
- TIXT N/A
- AMPH $10.89
- Revenue Growth
- TIXT 2.03
- AMPH 1.37
- 52 Week Low
- TIXT $2.13
- AMPH $20.39
- 52 Week High
- TIXT $4.60
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- TIXT 72.17
- AMPH 59.35
- Support Level
- TIXT $3.77
- AMPH $28.88
- Resistance Level
- TIXT $4.50
- AMPH $31.26
- Average True Range (ATR)
- TIXT 0.09
- AMPH 0.95
- MACD
- TIXT 0.07
- AMPH -0.29
- Stochastic Oscillator
- TIXT 96.20
- AMPH 22.69
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.